TransMedics raises 2026 revenue guidance to $764M-$774M as ENHANCE Part B and DENOVO catalysts shift to early 2027

Source: Seeking Alpha ·

Read the full story at Seeking Alpha

Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.

More from the world desk